Capital Insight Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-47,190
| Closed | -$1.82M | – | 168 |
|
|
2022
Q4 | $1.82M | Sell |
47,190
-7,776
| -14% | -$300K | 0.47% | 66 |
|
|
2022
Q3 | $2.92M | Sell |
54,966
-936
| -2% | -$49.8K | 0.79% | 41 |
|
|
2022
Q2 | $3.26M | Buy |
55,902
+1,367
| +3% | +$79.7K | 0.76% | 43 |
|
|
2022
Q1 | $4.16M | Sell |
54,535
-209
| -0.4% | -$16K | 0.85% | 34 |
|
|
2021
Q4 | $3.29M | Buy |
54,744
+1,537
| +3% | +$92.5K | 0.67% | 52 |
|
|
2021
Q3 | $2.98M | Buy |
53,207
+22,646
| +74% | +$1.27M | 0.65% | 57 |
|
|
2021
Q2 | $1.85M | Buy |
30,561
+8,520
| +39% | +$517K | 0.42% | 90 |
|
|
2021
Q1 | $1.55M | Buy |
+22,041
| New | +$1.55M | 0.38% | 99 |
|